Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jun;71(6):1894-1909.
doi: 10.1002/hep.31058. Epub 2020 Mar 24.

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection

Rae Jean Proeschold-Bell  1   2 , Donna M Evon  3 , Jia Yao  2 , Donna Niedzwiecki  4 , Christina Makarushka  2 , Kelly A Keefe  2 , Ashwin A Patkar  5   6 , Paolo Mannelli  5 , James C Garbutt  7   8 , John B Wong  9 , Julius M Wilder  10   11 , Santanu K Datta  12 , Terra Hodge  10 , Susanna Naggie  11   13   14 , Michael W Fried  3 , Andrew J Muir  10   11
Affiliations
Randomized Controlled Trial

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection

Rae Jean Proeschold-Bell et al. Hepatology. 2020 Jun.

Abstract

Background and aims: Hepatitis C virus (HCV) and alcohol use are patient risk factors for accelerated fibrosis progression, yet few randomized controlled trials have tested clinic-based alcohol interventions.

Approach and results: A total of 181 patients with HCV and qualifying alcohol screener scores at three liver center settings were randomly assigned to the following: (1) medical provider-delivered Screening, Brief Intervention, and Referral to Treatment (SBIRT), including motivational interviewing counseling and referral out for alcohol treatment (SBIRT-only), or (2) SBIRT plus 6 months of integrated colocated alcohol therapy (SBIRT + Alcohol Treatment). The timeline followback method was used to assess alcohol use at baseline and 3, 6, and 12 months. Coprimary outcomes were alcohol abstinence at 6 months and heavy drinking days between 6 and 12 months. Secondary outcomes included grams of alcohol consumed per week at 6 months. Mean therapy hours across 6 months were 8.8 for SBIRT-only and 10.1 for SBIRT + Alcohol Treatment participants. The proportion of participants exhibiting full alcohol abstinence increased from baseline to 3, 6, and 12 months in both treatment arms, but no significant differences were found between arms (baseline to 6 months, 7.1% to 20.5% for SBIRT-only; 4.2% to 23.3% for SBIRT + Alcohol Treatment; P = 0.70). Proportions of participants with any heavy drinking days decreased in both groups at 6 months but did not significantly differ between the SBIRT-only (87.5% to 26.7%) and SBIRT + Alcohol Treatment (85.7% to 42.1%) arms (P = 0.30). Although both arms reduced average grams of alcohol consumed per week from baseline to 6 and 12 months, between-treatment effects were not significant.

Conclusions: Patients with current or prior HCV infection will engage in alcohol treatment when encouraged by liver medical providers. Liver clinics should consider implementing provider-delivered SBIRT and tailored alcohol treatment referrals as part of the standard of care.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Hep ART study participant flowchart
Figure 2.
Figure 2.
Number of heavy drinking days
Figure 3:
Figure 3:
Number of alcohol abstinence days
See this image and copyright information in PMC

Comment in

References

    1. The Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. The Lancet Gastroenterol Hepatol. 2017;2(3):161–76. - PubMed
    1. Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology. 2008;48(2):418–31. - PubMed
    1. Younossi ZM, Zheng L, Stepanova M, Venkatesan C, Mir HM. Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2013;37(7):703–9. - PubMed
    1. Taylor AL, Denniston MM, Klevens RM, McKnight-Eily LR, Jiles RB. Association of hepatitis C virus with alcohol use among U.S. adults: NHANES 2003–2010. Am J Prev Med. 2016;51(2):206–15. - PubMed
    1. American Association for the Study of Liver Diseases. Recommendations for testing, managing, and treating hepatitis C. 2019. [Available from: https://www.hcvguidelines.org/.]

Publication types

MeSH terms